Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2011, Article ID 271062, 9 pages
http://dx.doi.org/10.1155/2011/271062
Research Article

The Apolipoprotein C-I Content of Very-Low-Density Lipoproteins Is Associated with Fasting Triglycerides, Postprandial Lipemia, and Carotid Atherosclerosis

1Hematology Research Group, Department of Clinical Medicine, University of Tromsø, 9037 Tromsø, Norway
2Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037, USA
3The Computational Medicine group, Atherosclerosis Research Unit, Department of Medicine, Karolinska Institute, Stockholm, Sweden
4Cerebrovascular Diseases and Atherosclerosis Research Group, Department of Clinical Medicine, University of Tromsø, Tromsø, Norway

Received 5 March 2011; Accepted 2 May 2011

Academic Editor: Angeliki Chroni

Copyright © 2011 John-Bjarne Hansen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Westerterp, W. De Haan, J. F. P. Berbée, L. M. Havekes, and P. C. N. Rensen, “Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL,” Journal of Lipid Research, vol. 47, no. 6, pp. 1203–1211, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. C. van der Hoogt, J. F. P. Berbée, S. M. S. Espirito Santo et al., “Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice,” Biochimica et Biophysica Acta, vol. 1761, no. 2, pp. 213–220, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. C. Jong, V. E. H. Dahlmans, P. J. J. Van Gorp et al., “In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway,” Journal of Clinical Investigation, vol. 98, no. 10, pp. 2259–2267, 1996. View at Google Scholar · View at Scopus
  4. M. C. Jong, M. J. J. Gijbels, V. E. H. Dahlmans et al., “Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1,” Journal of Clinical Investigation, vol. 101, no. 1, pp. 145–152, 1998. View at Google Scholar · View at Scopus
  5. E. Sehayek and S. Eisenberg, “Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway,” Journal of Biological Chemistry, vol. 266, no. 27, pp. 18259–18267, 1991. View at Google Scholar · View at Scopus
  6. J. A. Hubáček, J. Piťha, V. Adámková, Z. Škodová, V. Lánská, and R. Poledne, “Apolipoprotein E and apolipoprotein CI polymorphisms in the Czech population: almost complete linkage disequilibrium of the less frequent alleles of both polymorphisms,” Physiological Research, vol. 52, no. 2, pp. 195–200, 2003. View at Google Scholar · View at Scopus
  7. K. Conde-Knape, A. Bensadoun, J. H. Sobel, J. S. Cohn, and N. S. Shachter, “Overexpression of apoC-I in apoE-null mice: severe hypertriglyceridemia due to inhibition of hepatic lipase,” Journal of Lipid Research, vol. 43, no. 12, pp. 2136–2145, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. J. F. P. Berbée, C. C. Van Der Hoogt, D. Sundararaman, L. M. Havekes, and P. C. N. Rensen, “Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL,” Journal of Lipid Research, vol. 46, no. 2, pp. 297–306, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K. H. Weisgraber, R. W. Mahley, R. C. Kowal, J. Herz, J. L. Goldstein, and M. S. Brown, “Apolipoprotein C-I modulates the interaction of apolipoprotein E with β-migrating very low density lipoproteins (β-VLDL) and inhibits binding of β-VLDL to low density lipoprotein receptor-related protein,” Journal of Biological Chemistry, vol. 265, no. 36, pp. 22453–22459, 1990. View at Google Scholar · View at Scopus
  10. T. Gautier, D. Masson, M. C. Jong et al., “Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/apoCI-knocked out mice,” Journal of Biological Chemistry, vol. 277, no. 35, pp. 31354–31363, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Dumont, T. Gautier, J. P. Pais De Barros et al., “Molecular mechanism of the blockade of plasma cholesteryl ester transfer protein by its physiological inhibitor apolipoprotein CI,” Journal of Biological Chemistry, vol. 280, no. 45, pp. 38108–38116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. J. Lauer, D. Walker, N. A. Elshourbagy, C. A. Reardon, B. Levy-Wilson, and J. M. Taylor, “Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene,” Journal of Biological Chemistry, vol. 263, no. 15, pp. 7277–7286, 1988. View at Google Scholar · View at Scopus
  13. M. D. Curry, W. J. McConathy, J. D. Fesmire, and P. Alaupovic, “Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays,” Clinical Chemistry, vol. 27, no. 4, pp. 543–548, 1981. View at Google Scholar · View at Scopus
  14. G. Wahlberg, L. Holmquist, G. Walldius, and G. Annuzzi, “Effects of nicotinic acid on concentrations of serum apolipoproteins B, C-I, C-II, C-III and E in hyperlipidemic patients,” Acta Medica Scandinavica, vol. 224, no. 4, pp. 319–327, 1988. View at Google Scholar · View at Scopus
  15. P. Alaupovic, E. J. Schaefer, and W. J. McConathy, “Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease),” Metabolism: Clinical and Experimental, vol. 30, no. 8, pp. 805–809, 1981. View at Google Scholar · View at Scopus
  16. J. Björkegren, F. Karpe, R. W. Milne, and A. Hamsten, “Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma,” Journal of Lipid Research, vol. 39, no. 7, pp. 1412–1420, 1998. View at Google Scholar · View at Scopus
  17. G. Annuzzi, L. Holmquist, and L. A. Carlson, “Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 49, no. 1, pp. 73–81, 1989. View at Google Scholar · View at Scopus
  18. A. T. W. Notø, E. B. Mathiesen, J. Brox, J. Björkegren, and J. B. Hansen, “The ApoC-I content of VLDL particles is associated with plaque size in persons with carotid atherosclerosis,” Lipids, vol. 43, no. 7, pp. 673–679, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Björkegren, S. Boquist, A. Samnegård et al., “Accumulation of apolipoprotein C-I-rich and cholesterol-rich VLDL remnants during exaggerated postprandial triglyceridemia in normolipidemic patients with coronary artery disease,” Circulation, vol. 101, no. 3, pp. 227–230, 2000. View at Google Scholar · View at Scopus
  20. A. Hamsten, A. Silveira, S. Boquist et al., “The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men,” Journal of the American College of Cardiology, vol. 45, no. 7, pp. 1013–1017, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Björkegren, A. Silveira, S. Boquist et al., “Postprandial enrichment of remnant lipoproteins with ApoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 9, pp. 1470–1474, 2002. View at Publisher · View at Google Scholar
  22. O. Joakimsen, K. H. Bønaa, and E. Stensland-Bugge, “Reproducibility of ultrasound assessment of carotid plaque occurrence, thickness, and morphology: the Tromso Study,” Stroke, vol. 28, no. 11, pp. 2201–2207, 1997. View at Google Scholar · View at Scopus
  23. A. Vik, E. B. Mathiesen, A. T. W. Notø, B. Sveinbjørnsson, J. Brox, and J. B. Hansen, “Serum osteoprotegerin is inversely associated with carotid plaque echogenicity in humans,” Atherosclerosis, vol. 191, no. 1, pp. 128–134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. E. Hixson and D. T. Vernier, “Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI,” Journal of Lipid Research, vol. 31, no. 3, pp. 545–548, 1990. View at Google Scholar · View at Scopus
  25. J. Björkegren, A. Hamsten, R. W. Milne, and F. Karpe, “Alterations of VLDL composition during alimentary lipemia,” Journal of Lipid Research, vol. 38, no. 2, pp. 301–314, 1997. View at Google Scholar · View at Scopus
  26. C. Holm, G. Olivecrona, and M. Ottosson, “Assays of lipolytic enzymes,” Methods in Molecular Biology, vol. 155, pp. 97–119, 2001. View at Google Scholar · View at Scopus
  27. P. Tornvall, G. Olivecrona, F. Karpe, A. Hamsten, and T. Olivecrona, “Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 8, pp. 1086–1093, 1995. View at Google Scholar · View at Scopus
  28. G. Bengtsson-Olivecrona and T. Olivecrona, “Phospholiapase activity of milk lipoprotein lipase,” Methods in Enzymology, vol. 197, pp. 345–358, 1991. View at Google Scholar · View at Scopus
  29. R. H. Eckel, “Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases,” New England Journal of Medicine, vol. 320, no. 16, pp. 1060–1068, 1989. View at Google Scholar · View at Scopus
  30. Y. Xu, L. Berglund, R. Ramakrishnan et al., “A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E,” Journal of Lipid Research, vol. 40, no. 1, pp. 50–58, 1999. View at Google Scholar · View at Scopus
  31. N. S. Shachter, T. Ebara, R. Ramakrishnan et al., “Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein CI,” Journal of Clinical Investigation, vol. 98, no. 3, pp. 846–855, 1996. View at Google Scholar · View at Scopus
  32. J. Scott, T. J. Knott, D. J. Shaw, and J. D. Brook, “Localization of genes encoding apolipoproteins CI, CII, and E to the p13→cen region of human chromosome 19,” Human Genetics, vol. 71, no. 2, pp. 144–146, 1985. View at Google Scholar · View at Scopus
  33. M. C. Jong, M. H. Hofker, and L. M. Havekes, “Role of apoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 3, pp. 472–484, 1999. View at Google Scholar · View at Scopus
  34. T. I. Pollin, C. M. Damcott, H. Shen et al., “A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection,” Science, vol. 322, no. 5908, pp. 1702–1705, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. A. M. Bennet, E. Di Angelantonio, Z. Ye et al., “Association of apolipoprotein e genotypes with lipid levels and coronary risk,” Journal of the American Medical Association, vol. 298, no. 11, pp. 1300–1311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Cardona, S. Morcillo, M. Gonzalo-Marin, and F. J. Tinahones, “The apolipoprotein E genotype predicts postprandial hypertriglyceridemia in patients with the metabolic syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 5, pp. 2972–2975, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. C. Jong, J. H. Van Ree, V. E. H. Dahlmans, R. R. Frants, M. H. Hofker, and L. M. Havekes, “Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice,” Biochemical Journal, vol. 321, no. 2, pp. 445–450, 1997. View at Google Scholar · View at Scopus
  38. M. S. Weintraub, S. Eisenberg, and J. L. Breslow, “Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E,” Journal of Clinical Investigation, vol. 80, no. 6, pp. 1571–1577, 1987. View at Google Scholar · View at Scopus
  39. M. L. M. Grønholdt, B. G. Nordestgaard, B. M. Wiebe, J. E. Wilhjelm, and H. Sillesen, “Echo-lucency of computerized ultrasound images of carotid atherosclerotic plaques are associated with increased levels of triglyceride-rich lipoproteins as well as increased plaque lipid content,” Circulation, vol. 97, no. 1, pp. 34–40, 1998. View at Google Scholar · View at Scopus
  40. S. Jiao, T. G. Cole, R. T. Kitchens, B. Pfleger, and G. Schonfeld, “Genetic heterogeneity of lipoproteins in inbred strains of mice: analysis by gel-permeation chromatography,” Metabolism: Clinical and Experimental, vol. 39, no. 2, pp. 155–160, 1990. View at Publisher · View at Google Scholar · View at Scopus
  41. K. J. Williams and I. Tabas, “The response-to-retention hypothesis of atherogenesis reinforced,” Current Opinion in Lipidology, vol. 9, no. 5, pp. 471–474, 1998. View at Publisher · View at Google Scholar · View at Scopus
  42. D. B. Zilversmit, “Atherogenesis: a postprandial phenomenon,” Circulation, vol. 60, no. 3, pp. 473–485, 1979. View at Google Scholar · View at Scopus
  43. S. D. Proctor, D. F. Vine, and J. C. L. Mamo, “Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 11, pp. 2162–2167, 2004. View at Publisher · View at Google Scholar
  44. J. R. Patsch, G. Miesenbock, T. Hopferwieser et al., “Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state,” Arteriosclerosis and Thrombosis, vol. 12, no. 11, pp. 1336–1345, 1992. View at Google Scholar · View at Scopus
  45. S. Boquist, G. Ruotolo, R. Tang et al., “Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men,” Circulation, vol. 100, no. 7, pp. 723–728, 1999. View at Google Scholar · View at Scopus